Listing 1 - 10 of 10 |
Sort by
|
Choose an application
This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology.
Cardiology. --- Cancer --- Cancer Genetics and Genomics. --- Genetic aspects. --- Cardiovascular system --- Diseases.
Choose an application
This new volume of the book series Epigenetics and Human Health is dedicated to microRNAs (miRNAS), regulatory non-coding RNAs that have important roles in the control of gene expression both at posttranscriptional and transcriptional levels. Endogenous miRNAs regulate gene expression patterns in a sequence-specific manner. These short sequences may serve as potential therapeutic targets in the treatment of complex diseases including cancer, cardiovascular diseases, neurocognitive disorders, respiratory diseases and pathogenic infections. Moreover, miRNAs hold promise to be used as extensive diagnostic and prognostic markers of disease. miRNAs, Human Health and Disease is an essential reading for graduate and undergraduate students, researchers, and academics interested in the latest developments on non-coding RNA-mediated pathways associated with health and disease.
Epigenetics. --- Genetics. --- Molecular genetics. --- Cancer --- Genetics and Genomics. --- Molecular Genetics. --- Cancer Genetics and Genomics. --- Genetic aspects.
Choose an application
This book takes the reader on a journey through past and current research on the Major Histocompatibility Complex (MHC/HLA). It describes how it was discovered, what its biological function is and its application in medicine. The reader will learn about the molecular structure of the encoded molecules and different aspects of their role in medicine, including organ transplantation, their link to autoimmune diseases, cancer immunity, resistance to infectious diseases, and other related scientific areas, such as population genetics. In particular, the book focusses on the impact of MHC/HLA altered expression in tumours and their relevance in cancer immune escape and immunotherapy. It contains a large number of original figures and photographs of pioneers in the field, who made seminal contributions. Each chapter is supported by relevant key publications and enriched with a personal account of the early research that has contributed to our current understanding of the role of the major histocompatibility complex. This book is an excellent resource for all scientists in the biomedical life sciences who wish to gain insight into the discovery of the MHC/HLA and the role of this important genetic complex in health and disease.
Major histocompatibility complex. --- Immunology. --- Cancer. --- Genetics. --- Cancer --- Cancer Biology. --- Genetics and Genomics. --- Cancer Genetics and Genomics. --- Genetic aspects.
Choose an application
Genetics have a role in the presence of breast cancer, while the potential role of the immune system leads to consideration of immunotherapy in the treatment of the disease, particularly in metastatic triple-negative breast cancer. The sixth volume of the “Interdisciplinary Cancer Research” series, entitled “Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach” publishes comprehensive volumes on immune and genetic mechanisms of breast cancer diagnosis and prognosis. The role of molecular genetics, interleukins, chemokine receptor, and tumor-infiltrated lymphocytes-TILS in breast cancer are explained. Targeting myeloid determinants, SiRNA loaded in drug delivery nanosystems, nucleic acid and drug dual agent nanoplatforms, and oncolytic virotherapy are also discussed in the treatment of breast cancer, particularly in multidrug resistant and metastatic breast cancer. This interdisciplinary series is of special value to researchers working on immunology, genetics, and practitioners working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value to researchers, oncologists, geneticists, and immunologists who wish to extend their knowledge on breast cancer.
Cancer. --- Cancer --- Oncology. --- Tumors --- Immunotherapy. --- Cancer Biology. --- Cancer Therapy. --- Cancer Genetics and Genomics. --- Tumour Immunology. --- Treatment. --- Genetic aspects. --- Immunological aspects.
Choose an application
This open access book is a one-stop shop for all stakeholders interested in a deep understanding of the status quo of the healthcare sector in the UAE across all of its seven emirates and various private and public health systems. The book goes through the evolving journey of healthcare policy, delivery, and innovation celebrating success stories over the years while also highlighting persisting unmet needs. The book is authored by experts from various sectors in the UAE with representation from primary and specialist care and prevention, public health policy, regulatory affairs and reimbursement structures, clinical research, health informatics, health economics, medical education, training, and licensing. Particular topics of interest and unique to the UAE are also discussed, such as medical tourism. The chapters address specific disciplines' challenges and provide insights into future directions and roadmaps for desired change—an overall outlook for the UAE healthcare sector for the next 50 years. This is the first comprehensive book that addresses healthcare broadly in the UAE and is endorsed by the prestigious Emirates Oncology Society and the Emirates Medical Association.
Oncology. --- Cancer --- Cancer. --- Medical screening. --- Cancer Prevention. --- Cancer Therapy. --- Cancer Genetics and Genomics. --- Cancer Screening. --- Prevention. --- Treatment. --- Genetic aspects.
Choose an application
This book provides an in-depth exploration of the biology of prostate cancer, from its cellular origins to its clinical manifestations and therapeutic options. In addition to thoroughly covering a variety of diagnostic methods, radical procedures, radiation therapy, hormone therapy, and surgical techniques for prostatectomy, the book seeks to improve the understanding of the development of prostate cancer. Delving into the latest research and scientific advancements, the book starts by shedding light on the critical role of genetic susceptibility, redox signaling, apoptosis, epigenomics, transcriptomics, and metabolic reprogramming in prostate cancer development and progression. In the following section key concepts in prostate cancer diagnostics are covered. This includes the diagnostic, prognostic, and theranostic potential of miRNAs in prostate cancer; the necessity of biopsy; and the importance of histopathological and molecular markers in assessing aggressivity. It also explores recent advances in tumor markers for early detection and monitoring, as well as biological markers of therapeutic response. The book concludes by offering a wealth of knowledge on current treatment options for prostate cancer, including surgical treatments, hormone therapy for advanced cases, the use of apheresis in personalized cell-mediated treatment, pharmacogenomics and precision therapy challenges and perspectives, stereotactic radiotherapy, and treatment for castration-resistant prostate cancer. Scientists and medical professionals interested in basic and clinical research in urology and oncology will find this book to be a useful reference. It is a helpful tool for preparing medical specialization in pathology, oncology, urology, clinical biochemistry, laboratory medicine, diagnostic radiology, oncologic radiology, and related fields of cancer research. With its integrative approach to diagnostics and focus on recent scientific breakthroughs, this book empowers readers to deepen their understanding of prostate cancer and enhance their ability to advance basic and clinical research to treat this pervasive disease.
Cancer. --- Cancer --- Cancer Biology. --- Cancer Therapy. --- Cancer Genetics and Genomics. --- Cancer Imaging. --- Treatment. --- Genetic aspects. --- Imaging. --- Prostate --- Diagnosis. --- Prostatic Neoplasms. --- Prostatectomy. --- Precision Medicine.
Choose an application
This book deals with the first discriminant theory of linearly separable data (LSD), Theory3, based on the four ordinary LSD of Theory1 and 169 microarrays (LSD) of Theory2. Furthermore, you can quickly analyze the medical data with the misclassified patients which is the true purpose of diagnoses. Author developed RIP (Optimal-linear discriminant function finding the combinatorial optimal solution) as Theory1 in decades ago, that found the minimum misclassifications. RIP discriminated 63 (=26−1) models of Swiss banknote (200*6) and found the minimum LSD: basic gene set (BGS).In Theory2, RIP discriminated Shipp microarray (77*7129) which was LSD and had only 32 nonzero coefficients (first Small Matryoshka; SM1). Because RIP discriminated another 7,097 genes and found SM2, the author developed the Matryoshka feature selection Method2 (Program3), that splits microarray into many SMs. Program4 can split microarray into many BGSs. Then, the wide column LSD (Revolution-0), such as microarray (n
Statistics. --- Biometry. --- Diagnosis. --- Cancer --- Quantitative research. --- Mathematical optimization. --- Statistical Theory and Methods. --- Biostatistics. --- Cancer Genetics and Genomics. --- Data Analysis and Big Data. --- Discrete Optimization. --- Genetic aspects. --- Threshold logic.
Choose an application
The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.
Biopharmaceutics. --- Cancer --- Chemotherapy. --- Antineoplastic Agents. --- Neoplasms --- drug therapy. --- Cancer. --- Biology. --- Cancer Biology. --- Biological Sciences. --- Cancer Therapy. --- Cancers. --- Cancer Prevention. --- Cancer Genetics and Genomics. --- Treatment. --- Prevention. --- Genetic aspects.
Choose an application
Lung cancer is one of the most common cancers and the leading cause of deaths worldwide. The eighth volume of the “Interdisciplinary Cancer Research” series, entitled “Lung Cancer Pathophysiology: An Interdisciplinary Approach” publishes comprehensive reviews on the mechanisms of lung cancer. Fundamental elements of a lung cancer multidisciplinary team are discussed. The epithelial to mesenchymal transition in lung cancer, and the roles of tumor immune microenvironment, NK cells, RNA, micro-RNA, and long-non coding RNA in lung cancer are explained. A comprehensive genomic profiling in lung cancer in the era of immunotherapy approaches is also provided in this volume. This interdisciplinary series is of special value to researchers working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value to researchers, oncologists, and oncosurgeons who wish to extend their knowledge on lung cancer.
Cancer. --- Cancer --- Tumors --- Cytology. --- Oncology. --- Cancer Biology. --- Cancer Therapy. --- Cancer Genetics and Genomics. --- Tumour Immunology. --- Cell Biology. --- Treatment. --- Genetic aspects. --- Immunological aspects.
Choose an application
This book presents recent advancements, challenges, and clinical implications of molecular biomarkers in various cancers. This book highlights the clinical applications of biomarkers are extensive for cancer risk assessment, screening and early detection of cancer, accurate diagnosis, patient prognosis, prediction of response to therapy, and cancer surveillance and monitoring response. It also explores the progress of predictive biomarkers as an adjunctive tool to tumor immunotherapy in effectively identifying the efficacy of immune checkpoint inhibitors and discusses their future directions in achieving precision immuno-oncology. Further, the book examines the combination of next-generation sequencing and advanced computational data analysis approaches in the understanding of the genomic underpinnings of cancer development and progression. Towards the end, the chapter discusses the role of some commonly investigated phytochemicals and their epigenetic targets that are of particular interest in cancer prevention and cancer therapy. It is a must for researchers as well as advanced students and physicians in the field of cancer and clinical oncologists.
Early Detection of Cancer. --- Biomarkers, Tumor. --- Neoplasms --- diagnosis. --- therapy. --- Tumor markers --- Diagnostic use. --- Biomarkers, Tumor --- Molecular Diagnostic Techniques. --- therapeutic use. --- Cancer. --- Tumor markers. --- Cancer --- Cancer Biology. --- Tumour Biomarkers. --- Cancer Therapy. --- Cancer Genetics and Genomics. --- Treatment. --- Genetic aspects.
Listing 1 - 10 of 10 |
Sort by
|